U.S. Generic Drug Shortage: Structural Severity Backtest

Four Frequencies Framework | 2001–2025 | Federal Data & ASHP Database

Final Composite ⓘWeighted average of all four frequencies at the final data point in the timeline.

0.51

High band at 2025

Peak Composite ⓘHighest composite score recorded during the measured period, representing the worst overall structural condition.

0.54

2023 structural peak

Data Provenance ⓘClassification of data sources. FEDERAL-VERIFIED means the majority comes from filings, investigations, and databases produced under legal obligation.

FEDERAL-VERIFIED

BLS, FRED, FDA sources

Failure Mode ⓘThe dominant structural failure pattern the framework identified in this case.

Pricing Squeeze

Chronic capacity exit

How to Read This Chart

The Four Frequencies

Each line on this chart represents one of the Four Frequencies, scored from 0 (healthy) to 1 (critical). Permission measures the gap between what an organization is allowed to do and how effectively anyone checks that authority. Absence measures capabilities that should exist but don't: safety systems never built, risk functions left empty, testing layers skipped. Thinness measures concentration risk: how much depends on too few people, systems, or suppliers, so that losing any one causes disproportionate damage. Management measures the gap between what internal metrics report and what is structurally true. When the numbers look fine but the underlying conditions do not, this line rises.

The Composite

The thick gold line is the composite score: a weighted average of all four frequencies. The weights vary by case based on which structural dynamic dominated. A rising composite means the overall structural condition is deteriorating. A falling composite means constraints are being rebuilt. The composite does not predict when something will break. It measures how much structural strain exists when it does.

The Severity Bands

The colored background zones show severity thresholds, from dark green at the bottom (baseline health) through progressively warmer colors to dark red at the top (critical failure). When a line enters the orange-to-red zone above 0.55, that condition has moved beyond early warning into active degradation. When the composite enters that zone, multiple conditions are degrading simultaneously.

The Event Markers

Vertical dashed lines mark real-world events: crashes, regulatory changes, leadership departures, failures. The chart does not cause these events. It shows what structural conditions existed when they occurred. The gap between when the framework detects escalation and when the event happens is the structural lead time: the window during which the condition was readable in the data. Hover over any data point on the chart to see its exact value.

Composite Weighted average of all four frequencies. The thick gold line. Weights for this case are in the Methodology section below. Permission The gap between what an organization is allowed to do and how effectively anyone checks that authority. Absence Capabilities that should exist but don't: safety systems, risk functions, testing layers that were never built or were removed. Thinness Concentration risk: how much depends on too few people, systems, or suppliers, making the organization fragile to single points of failure. Management The gap between what internal metrics report and what is structurally true. When the numbers look fine but the underlying conditions do not.

Severity: 0–0.25 Baseline 0.25–0.40 Low 0.40–0.55 Moderate 0.55–0.70 High 0.70–0.85 Severe 0.85–1.0 Critical

The Framework Picked Up the Signal Three Years Before Shortages Spiked

The composite severity score crosses into the warning zone in 2006. Drug shortage counts did not spike above 200 until 2009. Federal pricing data from the Bureau of Labor Statistics shows exactly why: what hospitals pay for drugs kept going up, but what manufacturers get paid to make those drugs barely moved. That pricing squeeze has been continuous since 2001. It did not happen suddenly. It ground down generic manufacturing margins year after year until producers started exiting the market. The framework reads this as Thinness, which means concentration risk. Fewer manufacturers making the same drugs means one plant closure can trigger a nationwide shortage. And that is exactly what started happening.

The Headline Employment Number Hides the Problem

Total pharmaceutical manufacturing employment grew 20% from 2011 to 2024. That sounds healthy. But the growth is almost entirely in biologics and specialty drugs. Generic drug manufacturing, which is where the shortages actually happen, hollowed out underneath that rising headline number. The framework catches this as a Management signal: the metric everyone watches (total sector employment) is masking the structural vulnerability (generic capacity disappearing). If you only look at the top-line number, you would never know the system is breaking. The framework looks underneath.

How This Connects to the Full Forensic Analysis

The chart tracks a pricing squeeze — what manufacturers get paid versus what hospitals pay — as the Thinness mechanism driving producer exit. The full forensic analysis maps the wider architecture: a connected structural crisis where regulatory gaps (Permission), quality infrastructure erosion (Absence), and metrics that mask the hollowing out (Management) are all degrading simultaneously. The pricing squeeze is the single loudest signal. The full analysis shows how it connects to every other frequency in the system.

Sources: BLS Producer Price Index PCU32543254 (Pharmaceutical Manufacturing); BLS Employment IPUEN3254W010000000 (NAICS 3254); CPI Medical Care CPIMEDSL; CPI All Items CPIAUCSL; all via FRED API (Federal Reserve Economic Data, St. Louis Fed). FDA/ASHP Drug Shortage Database; FDA Warning Letters & Import Alerts; USP Medicine Supply Map (2020); Brookings Institution (Wosinska & Shi); GAO-14-194; GAO-24-106300.
Methodology: Severity 0–1 scale. Weights: Thinness 0.35 (domain keystone), Absence 0.30, Permission 0.20, Management 0.15. See DATA-PROVENANCE.md for full classification.